Market Access/ Views & Analysis/ Views and analysis Nice numbers at 20: what end-of-life evidence does NICE draw on? Leela Barham cancer, End of Life, EoL, NICE numbers at 20 0 Comment NICE may be 20 this year, but its policy on end-of-life (EoL) treatments – where NICE can recommend Share X Nice numbers at 20: what end-of-life evidence does NICE draw on? https://pharmaphorum.com/views-analysis-market-access/nice-numbers-at-20-what-end-of-life-evidence-does-nice-draw-on/
